Related Experiment Video

Updated: Jun 22, 2026

In vitro Organoid Culture of Primary Mouse Colon Tumors
07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes

K Takaku1, M Oshima, H Miyoshi

  • 1Banyu Tsukuba Research Institute (Merck), Japan.

Cell
|March 20, 1998
PubMed

Insights

Inactivating the DPC4 (SMAD4) gene promotes malignant progression in Apc-mutated intestinal tumors. This highlights SMAD4's role in colorectal cancer development and malignancy.

Area of Science:

  • Genetics and Molecular Biology
  • Cancer Biology
  • Developmental Biology

Background:

  • The DPC4 (SMAD4) gene is crucial for the transforming growth factor-beta (TGF-β) signaling pathway.
  • Mutations in tumor suppressor genes like DPC4 and APC are implicated in colorectal cancer.
  • Familial adenomatous polyposis (FAP) is a hereditary condition characterized by numerous colorectal polyps, often caused by APC mutations.

Purpose of the Study:

  • To investigate the role of DPC4 (SMAD4) in colorectal tumor progression.
  • To determine if DPC4 inactivation influences the malignancy of tumors in a mouse model of FAP.

Main Methods:

  • Inactivation of the mouse homolog of DPC4 (Smad4) in mice.
  • Generation of compound heterozygotes carrying both Dpc4 and Apc(delta716) mutations on the same chromosome via meiotic recombination.
  • Analysis of intestinal polyp development and tumor characteristics in Apc(delta716) heterozygotes versus compound heterozygotes.

Main Results:

  • Homozygous Dpc4 mutants were embryonic lethal; heterozygotes showed no overt abnormalities.
  • Compound heterozygotes with both Dpc4 and Apc(delta716) mutations developed intestinal polyps with increased malignancy.
  • These tumors exhibited enhanced stromal cell proliferation, submucosal invasion, cellular heterogeneity, and in vivo transplantability compared to Apc(delta716) heterozygotes.

Conclusions:

  • DPC4 (SMAD4) mutations significantly contribute to the malignant progression of colorectal tumors.
  • The study underscores the importance of the TGF-β signaling pathway, mediated by SMAD4, in controlling tumor aggressiveness.
  • Targeting SMAD4 may offer therapeutic strategies for more aggressive forms of colorectal cancer.

More Related Videos

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy05:21

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy

Published on: October 6, 2014

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...